Living with ICI-Heart Complications

  • Research type

    Research Study

  • Full title

    Exploring the Lived Experience of Patients with Cardiac Complications from Immune Checkpoint Inhibitors: A Qualitative Study

  • IRAS ID

    364146

  • Contact name

    Muhummad Sohaib Nazir

  • Contact email

    sohaib.nazir1@nhs.net

  • Sponsor organisation

    Royal Brompton & Harefield Hospitals, Part of Guy’s and St Thomas’ NHS Foundation Trust

  • Clinicaltrials.gov Identifier

    Unknown , Unknown

  • Duration of Study in the UK

    2 years, 0 months, 1 days

  • Research summary

    This study aims to better understand the experiences of people who develop heart problems after receiving a type of cancer treatment called immune checkpoint inhibitors (ICIs).
    ICIs are medicines that help the body’s immune system to recognise and fight different types of cancer, including lung cancer, skin cancer, and kidney cancer. For many patients, they have transformed cancer care and significantly improved survival. However, in a small number of people, these treatments can also affect the heart. This can lead to inflammation of the heart muscle (myocarditis), problems with heart rhythm, or heart failure.
    While there is growing research on how to diagnose and treat these complications, very little is known about what it is like for patients to live through them. Coping with both cancer and a serious heart condition can cause emotional distress, disrupt daily life, and even interrupt cancer treatment.
    This qualitative study will involve interviews with people who have experienced ICI-related cardiac complications. Through their stories, the research team hopes to gain new insights into the emotional, practical, and care-related challenges they face. The findings will help healthcare professionals improve communication, tailor support, and design more person-centred care pathways.
    Patient and public involvement (PPI) has already played an important role in shaping this study. Feedback from a cardiovascular patient advisory group has helped refine the interview questions and highlighted areas of patient experience that are most important to explore. They have also reviewed the Participant Information Sheet and the poster.

    By placing patient voices at the centre, this study aims to improve support and care for people living with the dual challenges of cancer and treatment-related heart disease.

  • REC name

    South East Scotland REC 01

  • REC reference

    25/SS/0117

  • Date of REC Opinion

    22 Dec 2025

  • REC opinion

    Further Information Favourable Opinion